<DOC>
	<DOCNO>NCT01310335</DOCNO>
	<brief_summary>The aim study investigate effect whole-body vibration plasma sclerostin level healthy young adult woman . Fifteen healthy young adult woman plan include study . All case train whole-body vibration ( WBV ) platform ( Power Plate ) 5 time week one week period . Training duration short beginning progress slowly . The amplitude vibration 2 mm frequency vibration 40 Hz . The subject ask report negative side effect adverse reaction train diary . Previbration postvibration ( , 10.minute 30.minute ) level plasma sclerostin measure first , second fifth day experiment . Sclerostin level measure human sclerostin ELISA kit .</brief_summary>
	<brief_title>Effect Whole-Body Vibration Plasma Sclerostin Level</brief_title>
	<detailed_description>Whole-body vibration strong osteogenic effect . The cyclic mechanical load bone stimulate osteocyte . Sclerostin , protein product SOST gene , osteocyte-specific cysteine knot-secreted glycoprotein potent inhibitor bone formation . Sost/sclerostin level report reduced mechanical stimulation . The aim study investigate effect whole-body vibration plasma sclerostin level healthy young adult woman .</detailed_description>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<criteria>Healthy woman , Women age vary 20 40 year Righthanded woman Lower extremity problem 1 . Orthopedic problem : shortness leg , congenital anomaly , etc . 2 . Joint disease ( arthritis , joint prosthesis , etc . ) 3 . Other painful pathology low extremity ( fracture , tendinitis , bursitis , etc . ) 4 . Circulation problem low extremity Dorsolumbar disease : Vertebral fract , disc hernia , spondylodiskitis , etc . Systemic disease case 1 . Systemic bone disease : osteoporosis , osteomalacia , Paget 's disease 2 . Hypertension ( &gt; 135 mmHg systolic , &gt; 85 mmHg diastolic ) 3 . Heart dis . ( coronary dis , conduction/rhythm prob , cardiac pacemaker ) 4 . Infectious diseases 5 . Endocrine disease ( Diabetes mellitus etc ) Neurological disease ( CNS problem , peripheral neuropathy ) Menstrual cycle disorder , amenorrhea , lactation , oral contraceptive use Cases ovulatory period ( 1116th day menses ) Obesity ( BMI &gt; 30 kg/m2 ) low BMI ( BMI &lt; 20 kg/m2 ) Vertigo Cognitive function disorder Women whose blood sample take time planned Women whose blood sample hemolyzed</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>sclerostin</keyword>
	<keyword>whole-body vibration</keyword>
</DOC>